Skip to main content
. Author manuscript; available in PMC: 2017 Nov 14.
Published in final edited form as: Anticancer Res. 2014 Apr;34(4):1939–1945.

Figure 2.

Figure 2

Individual patients/disease sites are represented by vertical bars on the X-axis. The best response per modified MacDonald criteria (%) is depicted on the Y-axis. Disease in four of the six patients was measurable. Of the two patients who were not measurable, one patient with stable disease (for 20 weeks) was assigned a value of +1% (+) and one patient was assigned a value of +25% for clinical progression (*).

HHS Vulnerability Disclosure